← Back to Search

Virus Therapy

Biophoton Therapy for Brain Disorders (Alzheimer Trial)

N/A

Recruiting

Research Sponsored by First Institute of All Medicines

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must be 18-years or older and stay in a hotel

Can provide a clinical diagnosis of a brain disorder

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-2 weeks, 0-4 weeks after starting the study treatment.

Awards & highlights

Alzheimer Trial Summary

This trial seeks to confirm the safety and effectiveness of a new biophoton therapy for brain disorders like Alzheimer's, dementia, stroke, etc. 80 people will participate in a triple-blinded, placebo-controlled study.

Who is the study for?

This trial is for adults with brain disorders like Alzheimer's, dementia, stroke, TBI, or Parkinson's. Participants need a caregiver to help them and must be able to give consent. They should speak English (or have translation) and women must test negative for pregnancy. People with untreated mental illnesses, reliance on ventilators, electronic implants in the brain or body, severe chronic diseases or life-threatening conditions can't join.Check my eligibility

What is being tested?

The study tests a Biophoton Generator called 'Biophotonizer' at Tesla MedBed Center in Butler, PA. It aims to confirm its safety and effectiveness against various brain disorders through a randomized trial where patients are blindly assigned to receive either the therapy or placebo without knowing which one they get.See study design

What are the potential side effects?

Previous studies suggest that biophoton therapy has been safe; however specific side effects are not detailed here. As with any medical intervention there may be risks involved which will be monitored throughout the study.

Alzheimer Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am over 18 and will be staying in a hotel.

Select...

I have a diagnosed brain disorder.

Alzheimer Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-2 weeks, 0-4 weeks after starting the study treatment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-2 weeks, 0-4 weeks after starting the study treatment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-2 weeks, 0-4 weeks after starting the study treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cognitive Capacity impacted by Biophoton Therapy

Overall Life Quality impacted by Biophoton Therapy

Secondary outcome measures

Blood Circulation impacted by Biophoton Therapy

Brain Bio-Energy impacted by Biophoton Therapy

Brain function change impacted by Biophoton Therapy

+1 more

Other outcome measures

Safety of the Study participant impacted by Biophoton Therapy

Alzheimer Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Treatment GroupExperimental Treatment1 Intervention

The 14 active Biophoton Generators packed with the same 32-Oz metal can will be labeled with a code and placed under a hotel bed. Each participant will rest on the bed during the entire study period for 4 weeks. Participants will receive biophotons inside of the biophoton field generated by 14 active Biophoton Generators

Group II: Control GroupPlacebo Group1 Intervention

The 14 inactive Biophoton Generators packed with the same 32-Oz metal can will be labeled with a code and placed under a hotel bed. Each participant will rest on the bed during the entire study period for the first 2 weeks. Then will be switched to the active treatment group for being treated for 4 weeks. Participants will receive placebo effect from the 14 inactive comparators.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

First Institute of All MedicinesLead Sponsor

2 Previous Clinical Trials

92 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment for this experiment ongoing?

"Affirmative. Clinicaltrials.gov confirms that this medical trial, which was first publicized on November 8th 2023, is actively recruiting 80 individuals across 1 clinical site."

Answered by AI

What is the scope of this clinical trial in terms of participant recruitment?

"Yes, the evidence on clinicaltrials.gov affirms that this research study is presently recruiting participants. It was first uploaded to the website on November 8th 2023 and has been amended since then; 80 individuals are needed at a single location for enrolment in this trial."

Answered by AI

What impact is this trial expected to make on the medical community?

"This clinical investigation, which is set to be evaluated within a span of 0-4 weeks after starting the medication, seeks to assess how Biophoton Therapy affects Cognitive Capacity. Additionally, it will evaluate Neurological Examination by a Study Physician with higher scores denoting better health; Brain function change using an EEG machine; Eye reaction time with shorter times indicating healthier results; and Blood Circulation measured through FALCON QUAD's ankle-brachial index where more even readings suggest improved circulation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Impact of a Biophoton Therapy on Patients With Brain Disorders

2023. "Impact of a Biophoton Therapy on Patients With Brain Disorders". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06147999.

All > Paid Studies Pittsburgh